ALTEOGEN INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 185,900 KRW | +3.28% |
|
-3.73% | +88.73% |
| 2023 | Alteogen Inc. Announces Clinical Trial of Tergase Showed Zero Incidence of ADA | CI |
| 2023 | ALTEOGEN Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ALTEOGEN INC. | Biopharmaceuticals | +3.28% | -3.73% | +88.73% | +252.08% | +1,465.47% | 7.14B |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- A196170 Stock
- Charts ALTEOGEN Inc.
- Comparison Chart
